e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Post-transplant complications: from pathogenesis to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Extracorporeal photopheresis in lung transplant:The initial experience in our hospital
M. Aguilar Pérez, M. T. Lazaro Carrasco de la Fuente, J. L. Bueno Cabrera, A. Morales de la Plaza, R. Laporta Hernandez, P. Ussetti Gil (Majadahonda, Spain)
Source:
International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Session:
Post-transplant complications: from pathogenesis to treatment
Session type:
Poster Discussion
Number:
3325
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Aguilar Pérez, M. T. Lazaro Carrasco de la Fuente, J. L. Bueno Cabrera, A. Morales de la Plaza, R. Laporta Hernandez, P. Ussetti Gil (Majadahonda, Spain). Extracorporeal photopheresis in lung transplant:The initial experience in our hospital. Eur Respir J 2014; 44: Suppl. 58, 3325
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Experience with application of ECMO in dubl lung transplantation
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment.
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
5 years follow-up of lung transplant recipients undergoing extracorporal photophoresis
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Effect of extracorporeal photopheresis on respiratory function in hematopoietic stem cell transplant recipients
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Extracorporeal photopheresis after lung transplantation: a 10-year single-centre experience
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008
Extracorporeal lung support (ECLS) as a bridge to lung transplant: the Pavia experience
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009
Lung complications after liver transplantation in children: The Swiss experience
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Initial treatment with CsA-AZA versus FK506-MPA: Comparison of early outcomes after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Osteoporosis in lung transplant patients
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Extracorporeal life support in lung failure and lung transplant bridging: when and how
Source: Virtual Congress 2020 – Extracorporeal life support in lung failure and lung transplant bridging: when and how
Year: 2020
Hypogammaglobulinemia in lung transplant candidates
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Rehabilitation success after bridging to lung transplantation with extracorporeal membrane oxygenation and mechanical ventilation
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1)
Year: 2013
The influence of extracorporeal photopheresis on NFκB signaling and cytokine expression in lung transplant patients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Clinical impact of the complications related to lung transplantation
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014
Extracorporeal life support (ECLS) as a bridge to lung transplantation (LTx)
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012
Lung transplantation for silicosis, report of 17 patients
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Pulmonary rehabilitation of lung transplant candidates in Hungary
Source: International Congress 2016 – Latest insights into pulmonary rehabilitation
Year: 2016
Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx)
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept